Abstract:We conducted a review to resolve whether there is relationship between depression and coronary heart disease or not. Depression is a mental health problem which is spread widely and most of physicians are well acquainted with this concept of depression. Diagnosis of depression disorder based on continuity of illness, etiology of illness and number of symptoms - all these discriminations should be reported during inspecting the link between depression and coronary heart disease. We review the mechanism of linking depression and coronary heart disease i.e. relationship between depression and inflammation, depression and autonomic dysfunction, CHD and autonomic dysfunction, depression and Sleep architecture disruption, depression and circadian rhythm disruption, CHD and circadian rhythm disruption, and depression and behavioral mechanism. There is bidirectional association between depression and coronary artery disease i.e. coronary artery disease can cause major depressive disorder and depression is risk factor for CAD and its complications. Major depression is a devastating comorbid disease that can make recovery difficult and increase risk of cardiac mortality and morbidity. We also go over the therapy options like Psychotherapy, Electroconvulsive therapy, Exercise etc. But there are some antidepressant medications also available for treating depression in patients associated with CAD. The antidepressant medications like SSRIs e.g. Sertraline, fluoxetine, citalopram etc. appears to be safe in individual with depression and concomitant CAD or unstable angina. However, some evidence suggests that SSRIs like tricyclics, may increase risk cardiac events and death when taken for long time. New classes of antidepressants have dual reuptake inhibition for serotonin and nor-epinephrine e.g. venlafaxine. These medications are slightly more successful than SSRIs in treating depression, but they also have some adverse effects. Selegiline transdermal form was recently licensed for the treatment of MDD. Oral selegiline is not effective antidepressant. When compared to oral selegiline, STS results in stable plasma levels of drug and increased drug concentration in the brain.

Advances in Research in the Connection between Depression and Coronary Heart Diseases

Depression and coronary heart disease: mechanisms, interventions, and treatments

New Insights into the Comorbidity of Coronary Heart Disease and Depression.

Coronary Heart Disease and Depression or Anxiety: A Bibliometric Analysis

Research progress on coronary artery disease patients complicated with depression

Effect of Depression on Hypersensitive C Reaction Protein Value in Coronary Heart Disease

Depression and the Risk of Coronary Heart Disease: a Meta-Analysis of Prospective Cohort Studies.

Depression and coronary heart disease: apprehending the elusive black dog

Depression and cardiovascular disease: Shared molecular mechanisms and clinical implications

Cardiovascular disease and depression: a narrative review

Research on Anxiety, Depression and the Related Factors in Patients with Heart Failure in Coronary Heart Disease

The Relationship between High-Sensitivity C-reactive Protein and Coronary Artery Disease

Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes.

Network Relationship of Depressive Disorder and Heart Disease

Depression: As a Risk Factor for Coronary Heart Disease

Coronary heart disease and depressive disorders, pathogenesis and actual features of the relationship

REVIEW OF FEMALE DEPRESSION AND CORONARY HEART DISEASE

Prevalence and management of depressive symptoms in coronary heart disease patients and relationship with cardiovascular prognosis: a prospective cohort study

Role of Depression in Secondary Prevention of Chinese Coronary Heart Disease Patients Receiving Percutaneous Coronary Intervention

Research Progress on the Correlation Between Alzheimer’s Disease and Depression

Depression, Anxiety and Cardiovascular Diseases